Anti-depression drugs fuel
record-setting drug costs
A Rand Corporation study recently found that doctors prescribe anti-depressants after
an average of only three minutes of conversation with their patients.
One of the reasons they're so quick to push drugs like Prozac, Zoloft and Paxil is
because of the incredible amount of marketing they are subjected to by the pharmaceutical
companies.
Because M.D.s don't have the time to check on real research about the diagnosis and
treatment of these drugs, they rely almost solely on drug makers to provide prescribing
information. The result is that powerful and potentially dangerous drugs are handed out
like candy.
The pharmaceutical companies have apparently been successful in their marketing
campaign, since antidepressant drugs are now the biggest contributors to a record-setting
drug cost increase of 16.8% last year, according to a study by the country's largest
independent pharmacy benefit manager, Express Scripts, Inc.
For consumers, the cost increases mean they will pay a bigger share of the expense in
the form of higher copayments, ranging from $5.00 for generic drugs to $25 or more for
selected, single-source brands. Employers and other pharmacy benefit plan sponsors
currently pay as much as 80% of a prescription's cost, which can amount to more than $100
each in some cases.
Employers are increasingly unable, or unwilling, to foot the enormous medical and drug
bills being incurred by their workers and many are greatly reducing health benefits to all
employees. Often, the alternative is to reduce other benefits and even salaries as well in
order to meet the health care costs. The end result is that all workers face the
possibility of less income or fewer benefits in order to continue to make drug companies
richer.
Drugs used to treat depression accounted for $4.76 of last year's $47.35 average
increase in per member per year drug costs. These drugs are expected to account for more
of the pharmacy benefit dollar than any other class of drugs by the end of 1999, according
to Express Scripts.
Antidepressant drugs are now the second most used class of drugs, just behind blood
pressure controlling antihypertensive drugs like ACE inhibitors. Antidepressant use
increased 11.9% last year, while use of antihypertensive drugs increased 9.7%.
The study also found usage growing for drugs that are marketed as ways to control high
blood pressure, combat diabetes, lower cholesterol, treat digestive problems, and open
sinuses.
Drug prices are higher across the board, too. In 1997-98, prices for all but one of the
nation's 50 most prescribed drugs increased, many several times and often by double
digits.
SOURCE: Express Scripts, Inc., Press Release, June 29, 1999.